Max Crispin

58PUBLICATIONS

355CO-AUTHORS

Manufacturing safety and qualityGene and molecular therapyInnate immunityIndustrial molecular engineering of nucleic acids and proteinsHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (58)

Sort by Publication Date:

|Jun 29, 2026

Translating Innovation to Clinic: End-to-End Bioprocess Development and cGMP Manufacturing of N332-GT5 HIV Vaccine Candidate for First-in-Human Trials HVTN144.

|Jun 08, 2026

mRNA delivery of a class 1/4 SARS-CoV-2 neutralizing antibody protects against diverse sarbecoviruses in a lethal mouse challenge model.

|May 07, 2026

Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design.

|Mar 04, 2026

Differential contributions of human oligosaccharyltransferase complexes OST-A and OST-B to HIV-1 envelope glycoprotein glycosylation.

Tugba Atabey, Ronald Derking, Maddy L Newby

|Feb 13, 2026

Rapidly acquired HIV-1 neutralization breadth in a rhesus V2 apex knockin mouse model after a single bolus immunization.

Amrit Raj Ghosh, Rumi Habib, Nitesh Mishra

|Feb 11, 2026

Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design.

Linling He, Yi-Zong Lee, Yi-Nan Zhang

Pageof 10

Frequent Collaborators

42 joint publications

Joel D Allen

26 joint publications

Andrew B Ward

13 joint publications

Gabriel Ozorowski

11 joint publications

Rogier W Sanders

10 joint publications

Ian A Wilson

9 joint publications

Dennis R Burton

9 joint publications

Christopher A Cottrell

7 joint publications

Shane Crotty

6 joint publications

Maddy Newby

5 joint publications

William R Schief